Form type | Sec Links | Description | Filing date | Reporting date |
---|---|---|---|---|
SC 13G | Report | Sep 12, 2024 | ||
SC 13G/A | Report | Feb 14, 2024 | ||
SC 13G/A | Report | ALIGOS THERAPEUTICS, INC. | Feb 14, 2024 | |
SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
SC 13G/A | Report | AMENDMENT NO. 2 | Feb 14, 2024 | |
SC 13G | Report | Feb 14, 2024 | ||
SC 13G | Report | Feb 14, 2024 | ||
SC 13G/A | Report | SC 13G/A | Nov 7, 2023 | |
SC 13G | Report | Nov 2, 2023 | ||
SC 13G/A | Report | ALIGOS THERAPEUTICS, INC. | Feb 14, 2023 | |
SC 13G/A | Report | AMENDMENT NO. 1 | Feb 14, 2023 | |
SC 13G/A | Report | Feb 13, 2023 | ||
SC 13G/A | Report | JHG PLC OWNS <5% | Feb 9, 2023 | |
SC 13G/A | Report | SC 13G/A | Feb 8, 2023 | |
SC 13G | Report | Dec 27, 2022 | ||
SC 13G | Report | Feb 14, 2022 | ||
SC 13G/A | Report | Feb 14, 2022 | ||
SC 13G | Report | SCHEDULE 13G | Feb 14, 2022 | |
SC 13G/A | Report | ALIGOS THERAPEUTICS, INC. | Feb 14, 2022 | |
SC 13G | Report | JANUS HENDERSON GROUP PLC OWNS 5.7% OF ALIGOS CIK 0001799448 | Feb 14, 2022 | |
SC 13G/A | Report | SC 13G/A | Feb 10, 2022 | |
SC 13G/A | Report | SC 13G/A | Feb 10, 2022 | |
SC 13G/A | Report | SEC SCHEDULE 13G | Feb 10, 2022 | |
SC 13G/A | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
SC 13G/A | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
SC 13G | Report | Aug 13, 2021 | ||
SC 13G | Report | ALIGOS THERAPEUTICS, INC. | Feb 16, 2021 | |
SC 13G | Report | SC 13G | Feb 16, 2021 | |
SC 13G | Report | SC 13G | Feb 11, 2021 | |
SC 13G | Report | SC 13G | Feb 11, 2021 | |
SC 13G | Report | SEC SCHEDULE 13G | Jan 11, 2021 | |
SC 13G | Report | SCHEDULE 13G | Oct 28, 2020 | |
SC 13G | Report | SEC SCHEDULE 13G | Oct 22, 2020 |